Skip to main content
Caplight Logo









Chitogel

Chitogel

Private
WellingtonHealthcare & Life Scienceshttps://chitogel.com

Last Round

Series A

Oct 8, 2024

Total Funding Raised

$60,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Chitogel operates in Healthcare & Life Sciences and is based in Wellington. Its latest recorded funding round was a VC Round in October 2024.

Chitogel is a medical device company that has developed a dissolvable, post-operative hydrogel material for use after endoscopic sinus surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Chitogel Comparables

Compare Chitogel with similar companies based on industry and business-model similarity.

Chitogel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hemostasis, LLC
90%
BioRegen Biomedical (Changzhou) Co., Ltd.
78%
Stryker Corporation
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Chitogel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 8, 2024
VC RoundOct 7, 2024
SeedJun 1, 2024
Pre SeedJul 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Chitogel Investors

Notable investors and investment history

Chitogel investors
InvestorRounds
Otago Innovation LtdPre Seed
McGeeverVC Round
LCO CapitalVC Round
Cure Kids VenturesPre Seed
Booster Innovation FundSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 55% MoM.

  • Jul 29, 2026

    Grew 27% QoQ, from 11 to 14 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Chitogel Filings

Explore SEC and related filing metadata, where available.

Chitogel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Chitogel's valuation, stock price, and market status.

Is Chitogel a public or private company?

Chitogel is a private company.

What is the current stock price of Chitogel?

Chitogel is a private company, so its shares have no public market price. Caplight tracks Chitogel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Chitogel worth (valuation)?

Valuation information for Chitogel is not publicly available.

Can I buy Chitogel stock?

Chitogel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Chitogel's last funding round?

Chitogel's most recent funding round was Series A on October 8, 2024.

Who are the main investors in Chitogel?

Key investors in Chitogel include McGeever.

Will Chitogel IPO soon?

No public IPO plans have been announced for Chitogel.

How can I track Chitogel secondary market activity?

Caplight tracks bids, offers, and trades in Chitogel's shares on secondary markets.

Firmographic Details

HeadquartersWellington
Employee Range11
Year Founded2014
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?